These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 209344)

  • 41. Synergistic effect of cephalexin with mecillinam.
    Otsuki M
    J Antibiot (Tokyo); 1981 Jun; 34(6):739-52. PubMed ID: 6268594
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Bacterial resistance to penicillins and cephalosporins.
    Rolinson GN
    Proc R Soc Lond B Biol Sci; 1971 Dec; 179(1057):403-10. PubMed ID: 4401418
    [No Abstract]   [Full Text] [Related]  

  • 43. Effects of subinhibitory amounts of ampicillin, amoxycillin and mecillinam on the adhesion of Escherichia coli bacteria to human urinary tract epithelial cells: a preliminary study.
    Svanborg-Edén C; Sandberg T; Stenqvist K; Ahlstedt S
    Infection; 1979; 7 Suppl 5():S452-5. PubMed ID: 229079
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Comparison of in vitro activity of mecillinam with other antimicrobial chemotherapeutic agents against Salmonella Shigella and El Tor Vibrio cholerae.
    Mhalu FS; Swai V; Runyoro D; Shao JF
    East Afr Med J; 1982 Oct; 59(10):676-81. PubMed ID: 6309499
    [No Abstract]   [Full Text] [Related]  

  • 45. Comparative potency of mecillinam and other beta-lactam antibiotics against Escherichia coli strains producing different beta-lactamases.
    Sougakoff W; Jarlier V
    J Antimicrob Chemother; 2000 Sep; 46 Suppl 1():9-14; discussion 63-5. PubMed ID: 11051618
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Comparison of antibacterial activity of mecillinam against recently isolated bacilli of 5 genera of Enterobacteriaceae from clinical materials with ampicillin, amoxicillin, cephalexin, nalidixic acid and pipemidic acid (author's transl)].
    Kosakai N; Oguri T
    Jpn J Antibiot; 1979 Aug; 32(8):812-8. PubMed ID: 226736
    [No Abstract]   [Full Text] [Related]  

  • 47. Murein and lipopolysaccharide biosynthesis in synchronized cells of Escherichia coli K 12 and the effect of penicillin G, mecillinam and nalidixic acid.
    Essig P; Martin HH; Gmeiner J
    Arch Microbiol; 1982 Sep; 132(3):245-50. PubMed ID: 6293397
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Blood levels and antibacterial activity of sera in patients treated with cyclacillin.
    Yourassowsky E; Schoutens E; Vanderlinden MP; Butzler JP; Sternon J
    Int J Clin Pharmacol; 1974 Mar; 9(2):120-4. PubMed ID: 4151243
    [No Abstract]   [Full Text] [Related]  

  • 49. Mutant isolation and molecular cloning of mre genes, which determine cell shape, sensitivity to mecillinam, and amount of penicillin-binding proteins in Escherichia coli.
    Wachi M; Doi M; Tamaki S; Park W; Nakajima-Iijima S; Matsuhashi M
    J Bacteriol; 1987 Nov; 169(11):4935-40. PubMed ID: 2822655
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Newer beta-lactam antibiotics.
    Hamilton-Miller JM; Brumfitt W
    Infection; 1974; 2(2):82-94. PubMed ID: 4367171
    [No Abstract]   [Full Text] [Related]  

  • 51. [Effects of ampicillin and cefazolin combined with mecillinam (author's transl)].
    Stille W; Bischof-Léger E; Helm EB
    Arzneimittelforschung; 1978; 28(10):1661-4. PubMed ID: 226099
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Mecillinam has potent in vitro activity against Chlamydophila pneumoniae ATCC VR1310.
    Bostock JM; Geary I; Eley A; Chopra I
    J Antimicrob Chemother; 2004 Jun; 53(6):1112. PubMed ID: 15166212
    [No Abstract]   [Full Text] [Related]  

  • 53. Cefepime, piperacillin-tazobactam, and the inoculum effect in tests with extended-spectrum beta-lactamase-producing Enterobacteriaceae.
    Thomson KS; Moland ES
    Antimicrob Agents Chemother; 2001 Dec; 45(12):3548-54. PubMed ID: 11709338
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Variety of beta-lactam supersensitive mutants of Escherichia coli K-12 (author's transl)].
    Okumura K
    Nihon Saikingaku Zasshi; 1980 Sep; 35(5):691-9. PubMed ID: 7017199
    [No Abstract]   [Full Text] [Related]  

  • 55. Suppression of lytic effect of beta lactams on Escherichia coli and other bacteria.
    Goodell EW; Lopez R; Tomasz A
    Proc Natl Acad Sci U S A; 1976 Sep; 73(9):3293-7. PubMed ID: 9642
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Filament formation of Escherichia coli treated with penicillin or cephalosporin C analogues, and its clinical significance. II. In vitro studies].
    Konno M; Ubukata K; Fujii R
    Kansenshogaku Zasshi; 1970 May; 44(2):72-85. PubMed ID: 4987949
    [No Abstract]   [Full Text] [Related]  

  • 57. Activity of mecillinam against Escherichia coli resistant to third-generation cephalosporins.
    Wootton M; Walsh TR; Macfarlane L; Howe RA
    J Antimicrob Chemother; 2010 Jan; 65(1):79-81. PubMed ID: 19915068
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Synthesis and antibacterial activity of new arylamido derivatives of 6 beta-aminopenicillanic, 7 beta-aminocephalosporanic and 7 beta-aminodesacetoxycephalosporanic acids.
    Kaloyanov N; Stoyanova R
    Arzneimittelforschung; 2000 Jul; 50(7):652-5. PubMed ID: 10965424
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Amdinocillin.
    Farrar WE
    Ann Intern Med; 1984 Sep; 101(3):389-90. PubMed ID: 6087706
    [No Abstract]   [Full Text] [Related]  

  • 60. Bactericidal action of beta-lactam antibiotics on Escherichia coli with particular reference to ampicillin and amoxycillin.
    Rolinson GN; Macdonald AC; Wilson DA
    J Antimicrob Chemother; 1977 Nov; 3(6):541-53. PubMed ID: 340439
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.